Td Asset Management Inc Reata Pharmaceuticals Inc Transaction History

Td Asset Management Inc

$107 Billion
Q3 2024

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 09, 2023	SELL	$79.22 - $105.37 $179,670 - $238,979	-2,268 Reduced 25.58%	6,600 $672,000
Q1 2023 May 10, 2023	SELL	$30.85 - $93.17 $125,004 - $377,524	-4,052 Reduced 31.36%	8,868 $806,000
Q4 2022 Feb 06, 2023	BUY	$22.15 - $42.11 $21,795 - $41,436	984 Added 8.24%	12,920 $490,000
Q2 2022 Aug 04, 2022	SELL	$20.71 - $36.5 $31,354 - $55,261	-1,514 Reduced 11.26%	11,936 $363,000
Q1 2022 May 10, 2022	SELL	$24.12 - $39.6 $528,469 - $867,636	-21,910 Reduced 61.96%	13,450 $441,000
Q4 2021 Feb 10, 2022	BUY	$25.61 - $110.96 $226,443 - $981,108	8,842 Added 33.34%	35,360 $932,000
Q3 2021 Nov 09, 2021	SELL	$100.0 - $143.02 $24,700 - $35,325	-247 Reduced 0.92%	26,518 $2.67 Million
Q2 2021 Aug 11, 2021	SELL	$78.27 - $151.29 $220,956 - $427,091	-2,823 Reduced 9.54%	26,765 $3.35 Million
Q1 2021 May 14, 2021	BUY	$94.25 - $132.81 $258,245 - $363,899	2,740 Added 10.21%	29,588 $2.95 Million
Q4 2020 Feb 16, 2021	BUY	$102.03 - $184.62 $596,977 - $1.08 Million	5,851 Added 27.87%	26,848 $3.32 Million
Q3 2020 Nov 10, 2020	BUY	$93.53 - $163.34 $93,530 - $163,340	1,000 Added 5.0%	20,997 $2.05 Million
Q2 2020 Aug 13, 2020	SELL	$126.3 - $176.56 $138,930 - $194,216	-1,100 Reduced 5.21%	19,997 $3.12 Million
Q1 2020 May 15, 2020	SELL	$124.16 - $247.74 $1.49 Million - $2.97 Million	-12,000 Reduced 36.26%	21,097 $3.05 Million
Q4 2019 Feb 11, 2020	BUY	$74.57 - $217.92 $420,873 - $1.23 Million	5,644 Added 20.56%	33,097 $6.77 Million
Q3 2019 Nov 07, 2019	BUY	$71.26 - $95.75 $549,842 - $738,807	7,716 Added 39.09%	27,453 $2.2 Million
Q2 2019 Aug 01, 2019	BUY	$77.72 - $94.35 $304,973 - $370,229	3,924 Added 24.82%	19,737 $1.86 Million
Q1 2019 May 08, 2019	BUY	$51.9 - $101.79 $10,380 - $20,358	200 Added 1.28%	15,813 $1.35 Million
Q4 2018 Feb 01, 2019	BUY	$48.76 - $76.44 $14,628 - $22,932	300 Added 1.96%	15,613 $876,000
Q3 2018 Nov 01, 2018	BUY	$35.64 - $92.06 $545,755 - $1.41 Million	15,313 New	15,313 $1.25 Million

Others Institutions Holding RETA

# of Institutions

Shares Held

62.7K

Call Options Held

Put Options Held

View Full List

About REATA PHARMACEUTICALS INC

Ticker RETA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 31,583,200
Description
Reata Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, identifies, develops, and commercializes novel therapeutics for patients with serious or life-threatening diseases. The company is developing Phase 3 clinical trial programs, including bardoxolone methyl (bardoxolone) for the treatment of patients with chronic kidney diseas...

More about RETA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Td Asset Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Td Asset Management Inc with notifications on news.

Account